Literature DB >> 32785693

Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.

Moitza Principe1, Marie Chanal1, Mirela Diana Ilie1,2, Audrey Ziverec1, Alexandre Vasiljevic3, Emmanuel Jouanneau4, Ana Hennino1, Gerald Raverot1,5,6, Philippe Bertolino1.   

Abstract

PURPOSE: Pituitary neuroendocrine tumors (PitNETs) are frequent intracranial neoplasms that present heterogenic characteristics. Little is known about the immune cell network that exists in PitNETs and its contribution to their aggressive behavior.
METHODS: Here we combined flow cytometry, t-SNE analysis, and histological approaches to define the immune landscape of surgically resected PitNETs. Xenografts of rodent pituitary tumor cells and resected PitNETs were performed in Rag2KO mice, in combination with in vitro analysis aimed at dissecting the role of pituitary tumor-cells in monocyte recruitment.
RESULTS: We report that gonadotroph PitNETs present an increased CD68+ macrophage signature compared to somatotroph, lactotroph, and corticotroph PitNETs. Transcriptomic and histological characterizations confirmed gonadotroph infiltrating macrophages expressed CD163, MRC-1, ARG1, and CSF1R M2 macrophage markers. Use of growth hormone (GH)3/GH4 somatotroph and LβT2/αT3.1 gonadotroph cells drove THP1 macrophage migration through respective expression of CCL5 or CSF1. Although both LβT2 and GH3 cells recruited F4/80 macrophages following their engraftment in mice, only LβT2 gonadotroph cells showed a capacity for M2-like polarization. Similar observations were performed on patient-derived xenografts from somatotroph and gonadotroph tumors. Analysis of clinical data further demonstrated a significant correlation between the percentage of CD68+ and CD163+ infiltrating macrophages and the invasive character of gonadotroph tumors.
CONCLUSIONS: Gonadotroph tumor drive the recruitment of macrophages and their subsequent polarization to an M2-like phenotype. More importantly, the association between infiltrating CD68+/CD163+ macrophages and the invasiveness of gonadotroph tumors points to macrophage-targeted immunotherapies being a potent strategy to limit the progression of gonadotroph PitNETs. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CSF1; invasion; macrophage; microenvironment; pituitary tumor

Year:  2020        PMID: 32785693     DOI: 10.1210/clinem/dgaa520

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Aggressive pituitary tumours and pituitary carcinomas.

Authors:  Gérald Raverot; Mirela Diana Ilie; Hélène Lasolle; Vincent Amodru; Jacqueline Trouillas; Frédéric Castinetti; Thierry Brue
Journal:  Nat Rev Endocrinol       Date:  2021-09-07       Impact factor: 43.330

2.  A Convolutional Neural Network Model for Detecting Sellar Floor Destruction of Pituitary Adenoma on Magnetic Resonance Imaging Scans.

Authors:  Tianshun Feng; Yi Fang; Zhijie Pei; Ziqi Li; Hongjie Chen; Pengwei Hou; Liangfeng Wei; Renzhi Wang; Shousen Wang
Journal:  Front Neurosci       Date:  2022-07-04       Impact factor: 5.152

Review 3.  Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches.

Authors:  Changxi Han; Shaojian Lin; Xingyu Lu; Li Xue; Zhe Bao Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-02       Impact factor: 5.555

Review 4.  Current and Emerging Medical Therapies in Pituitary Tumors.

Authors:  Nicolas Sahakian; Frédéric Castinetti; Thierry Brue; Thomas Cuny
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

5.  The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor.

Authors:  Ding Nie; Qiuyue Fang; Jianhua Cheng; Bin Li; Mingxuan Li; Hongyun Wang; Chuzhong Li; Songbai Gui; Yazhuo Zhang; Peng Zhao
Journal:  Cancer Immunol Immunother       Date:  2021-10-13       Impact factor: 6.630

Review 6.  Updating the Landscape for Functioning Gonadotroph Tumors.

Authors:  Georgia Ntali; Cristina Capatina
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.